对X射线诱导的抗辐射癌细胞进行光动力疗法
Hiromu Ito1, Yoshimi Shoji1,2, Megumi Ueno2
1Quantum RedOx Chemistry Team, Institute for Quantum Life Science (iQLS), Quantum Life and Medical Science Directorate (QLMS), National Institutes for Quantum Science and Technology (QST), Chiba 263-8555, Japan.
Pharmaceutics
|November 25, 2023
概括
光动力疗法 (PDT) 为抗X射线癌症提供了一个有前途的解决方案. 这种方法利用线粒体的活性氧物种 (ROS) 和氨酸载体 (HCP1) 来增强与激光照射相结合时的癌细胞破坏.
科学领域:
- 在瘤学瘤学.
- 生物化学 生物化学
- 医学物理 医学物理
背景情况:
- 放射治疗是癌症治疗的基石,但获得的电阻会导致治疗失败.
- 反应性氧物种 (ROS) 在辐射耐药性和光动力疗法 (PDT) 疗效方面都发挥着作用.
- 线粒体ROS诱导氨酸载体 (HCP1) 表达,增强PDT的细胞毒性作用.
研究的目的:
- 调查光动力疗法 (PDT) 在克服放射电阻方面的治疗潜力.
- 阐明PDT在X射线耐药癌细胞中的有效性背后的机制.
主要方法:
- 通过持续的X射线照射,建立了耐辐射的癌细胞系.
- 评估线粒体ROS的产生和HCP1在抗辐射细胞的表达.
- 在PDT中激光照射后评估氨酸积累和细胞毒性.
主要成果:
- 抗X射线的细胞表现出线粒体ROS生成的增加.
- 在抗辐射细胞中观察到高HCP1表达,促进氨酸的吸收.
- 激光照射的PDT在X射线耐药癌细胞中显示出增强的细胞毒性.
结论:
- 光动力疗法是治疗抗X射线癌症的可行和有前途的策略.
- 线粒体ROS的过度生成和抗性细胞中HCP1表达的升高增强了PDT的有效性.
- 向ROS和HCP1通路可以改善具有抗辐射恶性瘤的患者的治疗结果.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


